Takeover

Acquirers

Tenet Medicines, Inc.

Targets
1
Filings
1
Median premium
15%
First filing
Jun 4, 2024
Latest filing
Jun 4, 2024

Targets

CompanyTakeover scoreFilingsLatest
CLYMClimb Bio, Inc.31Jun 4, 2024

Deal filings

FiledCompanyFormPricePremium
Jun 4, 2024CLYMClimb Bio, Inc.DEFM14A$3.8415.4%